書籍情報から探す
Functional Characteristics and Pharmacokinetic Significance of Kidney-specific Organic Anion Transporters. OA T-K1 and OA T-K2, in the Urinary Excretion of Anionic Drugs
Satohiro MASUDA
Department of Pharmacy. Kyoto University Hospital, Faculty of Medicine, Kyoto University
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 91-103, 2003.
Department of Pharmacy. Kyoto University Hospital, Faculty of Medicine, Kyoto University
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 91-103, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
CYP Isoforms Involved in the Metabolism of Clarithromycin in vitro
Akio SUZUKI1, 2, Izumi IIDA1, Mitsuyo HIROTA1, Masayuki AKIMOTO1, Shohei HIGUCHI1, Toshio SUWA1, Masayoshi TANI3, Takashi ISHIZAKI4, Kan CHIBA2
1Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., 2Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, 3Department of General Surgery. International Medical Center of Japan, 4Department of Pharmacology and Therapeutics. Graduate School of Clinical Pharmacy, Kumamoto University
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 104-113, 2003.
1Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., 2Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, 3Department of General Surgery. International Medical Center of Japan, 4Department of Pharmacology and Therapeutics. Graduate School of Clinical Pharmacy, Kumamoto University
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 104-113, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Pharmacokinetic Interactions between Cyclosporine and Protease Inhibitors in HIV+ Subjects
Lynda FRASSETTO1, Thien THAI2, Anjana M AGGARWAL1, 2, 3, Patricia BUCHER2, Wolfgang JACOBSEN2, 4, Uwe CHRISTIANS2, 4, Leslie Z BENET2, Leslie C FLOREN2
1Department of Medicine, 2Biopharmaceutical Sciences, General Clinical Research Center, University of California, San Francisco, CA, USA
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 114-120, 2003.
1Department of Medicine, 2Biopharmaceutical Sciences, General Clinical Research Center, University of California, San Francisco, CA, USA
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 114-120, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Evaluation of Methods for Predicting Drug-drug Interactions by Monte Carlo Simulation
Motohiro KATO, Tatsuhiko TACHIBANA1, Kiyomi IT02, Yuichi SUGIYAMA3
1Pre-clinical Research Dept. I. Chugai Pharmaceutical Co. Ltd., 2School of Pharmaceutical Sciences, Kitasato University, 3Graduate School of Pharmaceutical Sciences, The University of Tokyo
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 121-127, 2003.
1Pre-clinical Research Dept. I. Chugai Pharmaceutical Co. Ltd., 2School of Pharmaceutical Sciences, Kitasato University, 3Graduate School of Pharmaceutical Sciences, The University of Tokyo
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 121-127, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Substrate Dependent Inhibition Profiles of Fourteen Drugs on CYP3A4 Activity Measured by A High Throughput LCMS/MS Method with Four Probe Drugs, Midazolam, Testosterone, Nifedipine and Terfenadine
Jagdish K. RACHA1*, Z. Sylvia ZHAO1, Nicholas OLEJNIK1, Nadine WARNER2, Rebecca CHAN3, David MOORE1, Hiroko SATOH1
1Non-Clinical Drug Safety Department, Hoffmann-La Roche Inc., Nutley. NJ. USA, 2Discovery. Roche Welwyn. Garden City. UK, 3Roche Bioscience, Palo Alto, CA, USA
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 128-138, 2003.
1Non-Clinical Drug Safety Department, Hoffmann-La Roche Inc., Nutley. NJ. USA, 2Discovery. Roche Welwyn. Garden City. UK, 3Roche Bioscience, Palo Alto, CA, USA
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 128-138, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Assessment of Tear Concentrations on Therapeutic Drug Monitoring. III. Determination of Theophylline in Tears by Gas Chromatography /Mass Spectrometry with Electron Ionization Mode
Masaharu NAKAJIMA1, *, Shinji SATO2, Susumu YAMATO1, Kenji SHIMADA1, Shuji KITAGAWA2, Akira HONDA3, Jiro MIYAMOT03, Harunobu HIRANO4, Mitsuyuki SUZUKI4, Hiroshi MIYAZAKI5
1Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 2Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 3Miyamoto Hospital, 4Saiseikai Niigata Daini Hospital, 5Department of Drug Metabolism and Disposition, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 139-145, 2003.
1Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 2Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 3Miyamoto Hospital, 4Saiseikai Niigata Daini Hospital, 5Department of Drug Metabolism and Disposition, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 139-145, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Three Novel Single Nucleotide Polymorphisms in UGT1A9
Mayumi SAEKI1, Yoshiro SAITO1, 2, Hideto JINNO1, 3, Kimie SAI1, 4, Kazuo KOMAMURA5, 6, Kazuyuki UENO7, Shiro KAMAKURA5, Masafumi KITAKAZE5, Kuniaki SHIRAO8, Hironobu MINAMI9, Atsushi OHTSU10, Teruhiko YOSHIDA11, Nagahiro SAIJO12, Shogo OZAWA1, 13, Jun-ichi SAWADA1, 2
1Project Team for Pharmacogenetics, 2Division of Biochemistry and Immunochemistry, 3Division of Environmental Chemistry, 4Division of Xenobiotic Metabolism and Disposition, 13Division of Pharmacology, National Institute of Health Sciences, 5Division of Cardiology, 6Department of Cardiovascular Dynamics Research Institute, 7Department of Pharmacy, National Cardiovascular Center, 8Gastrointestinal Oncology Division, 12Medical Oncology Division, National Cancer Center Hospital, 11Genetics Division. National Cancer Center Research Institute, 9Division of Oncology/Hematology, 10Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 146-149, 2003.
1Project Team for Pharmacogenetics, 2Division of Biochemistry and Immunochemistry, 3Division of Environmental Chemistry, 4Division of Xenobiotic Metabolism and Disposition, 13Division of Pharmacology, National Institute of Health Sciences, 5Division of Cardiology, 6Department of Cardiovascular Dynamics Research Institute, 7Department of Pharmacy, National Cardiovascular Center, 8Gastrointestinal Oncology Division, 12Medical Oncology Division, National Cancer Center Hospital, 11Genetics Division. National Cancer Center Research Institute, 9Division of Oncology/Hematology, 10Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 146-149, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Five Novel Single Nucleotide Polymorphisms in the EPHX1 Gene Encoding Microsomal Epoxide Hydrolase
Kisho SHISEKI1, Masaya ITODA1, Yoshiro SAITO1, 2, Yukiko NAKAJIMA1, Keiko MAEKAWA1, 2, Hideo KIMURA3, Yu-ichi GOTO3, Osamu SAITOH4, Masaaki KATOH4, Teiichi OHNUMA4, Mitsuru KAWAI4, Kenji SUGAI4, Taisuke OHTSUKI4, Chieko SUZUKI4, Narihiro MINAMI3, 4, Shogo OZAWA1, 5, Jun-ichi SAWADA1, 2
1Project team for Pharmacogenetics, 2Division of Biochemistry and Immunochemistry, 5Division of Pharmacology. National Institute of Health Sciences, 3National Institute of Neuroscience, 4National Center Hospital for Mental, Nervous and Muscular Disorders, National Center for Neurology and Psychiatry
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 150-153, 2003.
1Project team for Pharmacogenetics, 2Division of Biochemistry and Immunochemistry, 5Division of Pharmacology. National Institute of Health Sciences, 3National Institute of Neuroscience, 4National Center Hospital for Mental, Nervous and Muscular Disorders, National Center for Neurology and Psychiatry
DRUG METABOLISM AND PHARMACOKINETICS 18 (2) 150-153, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
